Adavosertib (AZD1775)

adavosertib · AstraZeneca

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Adavosertib (AZD1775), covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2 [Phase 2]